drugset / Trial / NCT00475813

Study of FLUTIFORM® VS Seretide® in Paediatric Subjects With Asthma

NCT00475813

Phase 3 Completed 211 enrolled Mundipharma Research Limited
RandomizedParallel-groupOpen-label

Summary

Study compares the efficacy and safety of FLUTIFORM® with Seretide® in the treatment of mild to moderate persistent asthma in pediatric subjects.

Timeline

Start
2007-03
Primary completion
2008-02
Completion
2008-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Fluticasone propionate Other / unclassified
Subject Formoterol Other / unclassified

Indications